Page 144 | Certara

On-Demand Webinar

How to Demonstrate Virtual Bioequivalence for Complex Dermal Generic Drugs

This webinar will explain how Certara expanded its PBPK Simcyp Simulator to incorporate an extensive…

CertaraJanuary 24, 2020

Poster

Visualization of Complex Trial Data in Non-Linear Mixed-Effect Analyses With Covariates

CertaraJanuary 17, 2020

Publication

Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110

CertaraJanuary 17, 2020

Publication

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

CertaraJanuary 17, 2020

On-Demand Webinar

AAPS Webinar – Pediatric Drug Development: Why It’s Critical to Submission Strategy and How Modeling, Regulatory, and Clinical Insights Shape Success

Learn how model-informed drug development, clinical pharmacology, and regulatory strategy support successful pediatric drug development…

CertaraJanuary 12, 2020

Blog

Using Model-based Meta-analysis to Inform Neuropathic Pain Drug Development

Model-based Meta-analysis is a framework to compare drugs used to treat diabetic peripheral neuropathy, post-herpetic…

CertaraDecember 19, 2019

Blog

Patient Engagement and Patient Centricity Series Part II: Types of Patient Advocates

Nirpal Virdee, Synchrogenix’s Global Head of Transparency and Disclosure recently sat down with Trishna Bharadia,…

CertaraNovember 11, 2019

Poster

Predicting Human Oral Bioavailability: Comparison of In Vivo Animal (Rat- Dog- and Monkey) Studies versus Mechanistic In Vitro In Vivo Extrapolation (IVIVE) Based Predictions

CertaraNovember 6, 2019

Poster

Fitting PBPK Model Parameters within Simcyp Engine Using Simcyp-R Package

CertaraNovember 6, 2019

Blog

ICER’s Unsupported Drug Price Increase Report: An Analysis

We analyze the drug-price watchdog, ICER’s (Institute for Clinical and Economic Review) “Report on Unsupported…

CertaraOctober 24, 2019

How to Demonstrate Virtual Bioequivalence for Complex Dermal Generic Drugs

Visualization of Complex Trial Data in Non-Linear Mixed-Effect Analyses With Covariates

Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

AAPS Webinar – Pediatric Drug Development: Why It’s Critical to Submission Strategy and How Modeling, Regulatory, and Clinical Insights Shape Success

Using Model-based Meta-analysis to Inform Neuropathic Pain Drug Development

Patient Engagement and Patient Centricity Series Part II: Types of Patient Advocates

Predicting Human Oral Bioavailability: Comparison of In Vivo Animal (Rat- Dog- and Monkey) Studies versus Mechanistic In Vitro In Vivo Extrapolation (IVIVE) Based Predictions

Fitting PBPK Model Parameters within Simcyp Engine Using Simcyp-R Package

ICER’s Unsupported Drug Price Increase Report: An Analysis

Newsletter sign up

Quick links

Solutions

Contact